COVID-19

April 12, 2021

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

April 2, 2021

Provisional Death Counts for Coronavirus Disease 2019 (COVID-19) | Pfizer-BioNtech announce positive topline results of pivotal COVID-19 vaccine study in adolescents | FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use

March 26, 2021

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019 | Post-acute COVID-19 syndrome | Are vaccines safe in patients with Long COVID? A prospective observational study

March 19, 2021

Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19 | Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

March 8, 2021

Difference in SARS-CoV-2 attack rate between children and adults may reflect bias | Update on long COVID prevalence estimate | Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 | Dexamethasone in Hospitalized Patients with Covid-19

March 3, 2021

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts | Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial | Sequelae in Adults at 6 Months After COVID-19 Infection

February 22, 2021

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study | Multisystem Inflammatory Syndrome in Children (MIS-C) | Decreased SARS-CoV-2 viral load following vaccination

February 8, 2021

Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients | Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization | Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2

February 1, 2021

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial | Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial | SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

January 25, 2021

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings | The impact of Spike mutations on SARS-CoV-2 neutralization | Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States. 

Scroll to Top